Decreased expression of the mRNA for somatostatin in the periventricular nucleus of depression-model rats

K Zhang1, K Hamanaka, I Kitayama

  • 1Department of Psychiatry, Mie University School of Medicine, Tsu, Japan. zhangkai@clin.medic.mie-u.ac.jp

Life Sciences
|August 28, 1999
PubMed

Insights

Rats modeled for depression showed reduced somatostatin (SRIF) mRNA expression in the hypothalamus. This suggests hypothalamic SRIF neurons may be hypofunctional in depression pathophysiology.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Psychiatry

Background:

  • Hypothalamic somatostatin (SRIF) neurons play a role in regulating various physiological functions.
  • Altered SRIFergic activity has been implicated in mood disorders, but its specific role in depression models requires further investigation.

Purpose of the Study:

  • To investigate the functional status of hypothalamic SRIF neurons in a rat model of depression.
  • To examine the relationship between SRIF expression, SRIF levels, and growth hormone (GH) concentration in this depression model.

Main Methods:

  • Male Wistar rats were subjected to intermittent walking stress to induce a depression model.
  • Spontaneous running activity was measured to categorize rats into depression and partial-recovery groups.
  • In situ hybridization was used to quantify SRIF mRNA expression in the periventricular nucleus (PeN).
  • SRIF levels in the stalk-median eminence (SME) and plasma GH concentrations were measured.

Main Results:

  • Rats in the depression model exhibited significantly lower SRIF mRNA expression in the PeN compared to control and partial-recovery groups.
  • The depression model group showed reduced SRIF levels in the SME.
  • Plasma GH concentrations were elevated in the depression model group.

Conclusions:

  • Reduced SRIF mRNA expression in the PeN is associated with the pathophysiology of this rat model of depression.
  • These findings support the hypothesis of hypothalamic SRIF neuron hypofunctionality in depression.
  • Altered SRIFergic signaling may contribute to neuroendocrine dysregulation observed in depression.